StockNews.com assumed coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a report issued on Monday morning. The brokerage issued a sell rating on the medical research company’s stock.
OpGen Stock Performance
NASDAQ:OPGN opened at $0.60 on Monday. OpGen has a one year low of $0.17 and a one year high of $3.84. The stock has a market cap of $7.55 million, a PE ratio of -0.09 and a beta of -0.71. The stock has a 50 day moving average price of $0.56 and a 200 day moving average price of $0.51.
About OpGen
Further Reading
- Five stocks we like better than OpGen
- Options Trading – Understanding Strike Price
- It’s Time to Buy Into the Super Micro Computer Stock Implosion
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Merger or Not, Albertson’s Companies is a Good Buy
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 Cheap Stocks That Shouldn’t Be So
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.